Larimar Therapeutics Inc (LRMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Operating Expenses | 12,106 | 14,396 | 10,335 | 11,399 | 6,674 |
| Operating Income | -12,106 | -14,396 | -10,335 | -11,399 | -6,674 |
| Other Income | 18 | 192 | 61 | 69 | 0 |
| Pre-tax Income | -12,088 | -14,204 | -10,274 | -11,330 | -6,674 |
| Net Income Continuous | -12,088 | -14,204 | -10,274 | -11,330 | -6,674 |
| Net Income | $-12,088 | $-14,204 | $-10,274 | $-11,330 | $-6,674 |
| EPS Basic Total Ops | -0.76 | -0.62 | -0.64 | -1.21 | -1.10 |
| EPS Basic Continuous Ops | -0.76 | -0.63 | -0.64 | -1.21 | -1.10 |
| EPS Diluted Total Ops | -0.76 | -0.62 | -0.64 | -1.21 | -1.10 |
| EPS Diluted Continuous Ops | -0.76 | -0.63 | -0.64 | -1.21 | -1.10 |
| EBITDA(a) | $-12,038 | $-14,347 | $-10,274 | $-11,367 | $-6,651 |